Middle East & Africa Glycomic Therapeutics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Glycomic Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Glycomic Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Glycomic Therapeutics Market Regional Analysis

6.2 Middle East & Africa Glycomic Therapeutics Market Revenue 2020-2028 (US$ Million)

6.3 Middle East & Africa Glycomic Therapeutics Market Forecast Analysis

7. Middle East & Africa Glycomic Therapeutics Market Analysis – by Class

7.1 Isolated and Synthetic

7.1.1 Overview
7.1.2 Isolated and Synthetic: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Middle East & Africa Glycomic Therapeutics Market Analysis – by Structures

8.1 Glycoproteins

8.1.1 Overview
8.1.2 Glycoproteins: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Targeting Sialic Acid

8.2.1 Overview
8.2.2 Targeting Sialic Acid: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Proteoglycans

8.3.1 Overview
8.3.2 Proteoglycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Targeting Glycosaminoglycans

8.4.1 Overview
8.4.2 Targeting Glycosaminoglycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans

8.5.1 Overview
8.5.2 Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Targeting Glycosphingolipids

8.6.1 Overview
8.6.2 Targeting Glycosphingolipids: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Middle East & Africa Glycomic Therapeutics Market Analysis – by Indications

9.1 Thrombosis & Chemoprophylaxis

9.1.1 Overview
9.1.2 Thrombosis & Chemoprophylaxis: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Anaemia

9.2.1 Overview
9.2.2 Anaemia: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Anti-Adhesive & Anti-Inflammatory

9.3.1 Overview
9.3.2 Anti-Adhesive & Anti-Inflammatory: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Cataracts

9.4.1 Overview
9.4.2 Cataracts: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.5 Gaucher's Disease

9.5.1 Overview
9.5.2 Gaucher's Disease: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.6 MPS-1 & IV

9.6.1 Overview
9.6.2 MPS-1 & IV: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.7 Cancer

9.7.1 Overview
9.7.2 Cancer: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.8 Alzheimer's Disease

9.8.1 Overview
9.8.2 Alzheimer's Disease: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.9 Influenza Type A & B

9.9.1 Overview
9.9.2 Influenza Type A & B: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Middle East & Africa Glycomic Therapeutics Market Analysis – by Mode of Action

10.1 Inhibits Neuraminidase

10.1.1 Overview
10.1.2 Inhibits Neuraminidase: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate

10.2.1 Overview
10.2.2 Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Erythropoietin & Enzyme Replacement Therapy

10.3.1 Overview
10.3.2 Erythropoietin & Enzyme Replacement Therapy: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 Tissue Plasminogen Activator

10.4.1 Overview
10.4.2 Tissue Plasminogen Activator: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.5 Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3

10.5.1 Overview
10.5.2 Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.6 Beta & Gamma Interferons

10.6.1 Overview
10.6.2 Beta & Gamma Interferons: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.7 Others

10.7.1 Overview
10.7.2 Others: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Middle East & Africa Glycomic Therapeutics Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East & Africa Glycomic Therapeutics Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
11.2.1.1.2 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.1.3 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.1.4 South Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.2 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
11.2.1.2.2 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.2.3 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.2.4 Saudi Arabia: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.3 UAE: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
11.2.1.3.2 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.3.3 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.3.4 UAE: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Mode of Action

11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Class
11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Structures
11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Indications
11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Glycomic Therapeutics Market Breakdown, by Mode of Action

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Protalix Biotherapeutics

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 BioMarin Pharmaceutical Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Genzyme Corporation (Sanofi)

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bayer AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlaxoSmithKline plc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 F. Hoffmann-La Roche Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East & Africa Glycomic Therapeutics Market